Select a community
All Communities
Home > Community Treatment Reports > AVP-923 (DM/Q) Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


AVP-923 (DM/Q) Treatment Report

What is AVP-923 (DM/Q)? A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA) in Patients With Amyotrophic Lateral Sclerosis and Multiple Sclerosis Read more...Click to read more below


Reasons taken

3 patients in the community are taking or have taken AVP-923 (DM/Q).

Reason # Patients Percentage of patients
Emotional lability 2 66%
Other 1 33%

Dosages

Based on the patients currently taking AVP-923 (DM/Q).

  30 mg daily 80 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking AVP-923 (DM/Q) or how long patients were taking AVP-923 (DM/Q) before stopping.

Currently Taking AVP-923 (DM/Q)

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0
1

Stopped Taking AVP-923 (DM/Q)

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
0
0
Why Patients Stopped Taking AVP-923 (DM/Q) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 1 100% Side effects too severe: 100%

Report created on November 08, 2009.